179 related articles for article (PubMed ID: 26967561)
1. Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects.
Mori F; Ferraiuolo M; Santoro R; Sacconi A; Goeman F; Pallocca M; Pulito C; Korita E; Fanciulli M; Muti P; Blandino G; Strano S
Oncotarget; 2016 Apr; 7(15):20532-48. PubMed ID: 26967561
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
Zheng M; Sun X; Li Y; Zuo W
Tumour Biol; 2016 Jun; 37(6):8189-96. PubMed ID: 26715279
[TBL] [Abstract][Full Text] [Related]
3. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA ZFAS1 interacts with miR-150-5p to regulate Sp1 expression and ovarian cancer cell malignancy.
Xia B; Hou Y; Chen H; Yang S; Liu T; Lin M; Lou G
Oncotarget; 2017 Mar; 8(12):19534-19546. PubMed ID: 28099946
[TBL] [Abstract][Full Text] [Related]
5. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression.
Li J; Chen Y; Zhao J; Kong F; Zhang Y
Cancer Lett; 2011 May; 304(1):52-9. PubMed ID: 21354697
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
7. MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1.
Xie Q; Wang S; Zhao Y; Zhang Z; Qin C; Yang X
Oncotarget; 2017 Mar; 8(13):22003-22013. PubMed ID: 28423543
[TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.
Liu B; Tian Y; Li F; Zhao Z; Jiang X; Zhai C; Han X; Zhang L
Oncol Rep; 2016 Jun; 35(6):3178-84. PubMed ID: 27109339
[TBL] [Abstract][Full Text] [Related]
9. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X
Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241
[TBL] [Abstract][Full Text] [Related]
10. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
11. miR-488 acts as a tumor suppressor gene in gastric cancer.
Zhao Y; Lu G; Ke X; Lu X; Wang X; Li H; Ren M; He S
Tumour Biol; 2016 Jul; 37(7):8691-8. PubMed ID: 26738864
[TBL] [Abstract][Full Text] [Related]
12. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.
Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G
Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479
[TBL] [Abstract][Full Text] [Related]
13. Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.
Pogribny IP; Filkowski JN; Tryndyak VP; Golubov A; Shpyleva SI; Kovalchuk O
Int J Cancer; 2010 Oct; 127(8):1785-94. PubMed ID: 20099276
[TBL] [Abstract][Full Text] [Related]
14. Direct targeting of HGF by miR-16 regulates proliferation and migration in gastric cancer.
Li S; Zhang H; Wang X; Qu Y; Duan J; Liu R; Deng T; Ning T; Zhang L; Bai M; Zhou L; Wang X; Ge S; Ying G; Ba Y
Tumour Biol; 2016 Nov; 37(11):15175-15183. PubMed ID: 27683052
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J
Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223
[TBL] [Abstract][Full Text] [Related]
17. Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family.
Suliman MA; Zhang Z; Na H; Ribeiro AL; Zhang Y; Niang B; Hamid AS; Zhang H; Xu L; Zuo Y
Int J Mol Med; 2016 Sep; 38(3):776-84. PubMed ID: 27460529
[TBL] [Abstract][Full Text] [Related]
18. MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA.
Al-Haidari AA; Syk I; Thorlacius H
Oncotarget; 2017 Feb; 8(9):14887-14896. PubMed ID: 28146427
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
